Home / News & Videos / News / Leadership, Awards & Events /

Moderna’s Tal Zaks Recipient of Ben-Gurion Award

Moderna’s Tal Zaks Recipient of Ben-Gurion Award

November 22, 2020

Leadership, Awards & Events, Press Releases

Ben-Gurion University of the Negev (BGU) honored individuals who have made significant contributions in the spirit of Israel’s first prime minister, David Ben-Gurion, including Moderna Chief Medical Officer Dr. Tal Zaks.

Moderna Chief Medical Officer
Dr. Tal Zaks

An M.D., Ph.D. graduate of BGU, Dr. Zaks is spearheading the vaccine research effort for Moderna, which just announced that its mRNA-1273 coronavirus vaccine is 94.5% effective. It will be available in the U.S. and Israel, pending further study and approvals.

Originally from Ra’anana, Israel, Zaks moved to the United States in 1996 and first worked on cancer research at the National Institutes of Health. He joined the Boston-based Moderna in 2015.

The award ceremony is held annually on Ben-Gurion Day, an Israeli holiday marking David Ben-Gurion’s death. Ben-Gurion was a founder of Israel and its first prime minister, as well as the namesake of the University.

Click here to view the virtual ceremony, which was held on Sunday, November 22, 2020.

“All eyes around the world are focused on the critical work that Ben-Gurion University alumnus Dr. Tal Zaks is overseeing at Moderna to eradicate this coronavirus pandemic,” says American Associates, Ben-Gurion University of the Negev Chief Executive Officer Doug Seserman.

“There is no better example of David Ben-Gurion’s vision to share Israel’s resources and brain power with the world than the success being achieved by Dr. Zaks at Moderna. We congratulate him and are proud he is a recipient of the prestigious Ben-Gurion Award.”

“David Ben-Gurion’s vision continues to resonate strongly with these award winners,” says BGU President Prof. Daniel Chamovitz. “We recognize their unique contributions – scientific breakthroughs alongside community action. Those were Ben-Gurion’s values, and they are our values.”

In August 2020, AABGU met with Dr. Zaks to discuss Moderna’s progress in the race to develop a COVID-19 vaccine, and how his education at BGU’s Joyce and Irving Goldman Medical School shaped his career.

Dr. Zaks shared his insight and optimism about the reality of a vaccine becoming available by early 2021. Click on the image below to watch the webinar in its entirety.

Read More About Tal Zaks in The Forward >>

About American Associates, Ben-Gurion University of the Negev

American Associates, Ben-Gurion University of the Negev (AABGU) plays a vital role in sustaining David Ben-Gurion’s vision: creating a world-class institution of education and research in the Israeli desert, nurturing the Negev community and sharing the University’s expertise locally and around the globe. Activities include showcasing BGU’s academic excellence and cutting-edge research through educational programs, events and informative communications. AABGU’s main purpose is to support Ben-Gurion’s vision and the university that bears his name by creating a community of Americans committed to improving the world tomorrow from the heart of the Israeli desert today.

Media Contact:
Andrew Lavin
A. Lavin Communications
516-944-4486
alc@alavin.com